top of page

Seed Grant Program

The Need for ROS1+ Research

ROS1+ cancer is rare, occurring in only 1%-2% or non-small cell lung cancer cases--this means fewer than 2000 cases are diagnosed in the USA each year. Many oncologists will never meet a patient who has ROS1+ lung cancer, and few clinics will see enough ROS1+ patients to be able to gather data on a sizeable cohort. But it is research that saves lives. It is for this reason that the ROS1ders created the ROS1+ Cancer Innovation Award.

What We Fund

The ROS1+ Cancer Innovation Award seeks high-risk, high-reward research projects focused on ROS1+ cancer. The award provides a one-year grant of up to $75,000 to fund pre-clinical, translational, or clinical research critical to improve outcomes for ROS1+ cancer..The program is open to investigators who hold a doctorate and a faculty appointment anywhere in the world.

How to Apply

ROS1+ Cancer Innovation Award uses a two-step application process: a Letter of Intent followed by a Full Application.  Templates and detailed instructions for applying can be found at proposalcentral.com. Be sure to read those instructions in case any instructions were changed, added, or deleted after this RFA was issued. For more information about this opportunity, please see the ROS1+ Cancer Innovation Award Request for Application.

Important Dates

All deadlines occur at 11:59 pm Eastern Time on the stated dates.

RFA Issued
03/27/2024
Letter of Intent Deadline
05/03/2024
Successful LOIs Invited to Submit Full Application
06/15/2024
Full Application Deadline
08/04/2024
Successful Awardees Notified
10/15/2024
bottom of page